Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (1-10 of 430) with videos related to

Pageof 43
Sort By:
Oncology (Williston Park, N.Y.)|April 6, 2010
Improving our use and understanding of antibodies in B-cell lymphomasChristopher R Flowers
Oncology (Williston Park, N.Y.)|September 17, 2014
Routine use of maintenance therapy in follicular lymphoma: examine the rationale for maintenance use before uniformly adopting a strategyChristopher R Flowers
Expert Review of Vaccines|June 5, 2007
BiovaxID idiotype vaccination: active immunotherapy for follicular lymphomaChristopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Reply to H.J.A. Adams et alQian Shi, Christopher R Flowers
Cancer|November 19, 2013
Racial differences in chronic lymphocytic leukemia. Digging deeperChristopher R Flowers, Barbara Pro
Pharmacoeconomics|June 26, 2004
The role of cost-effectiveness analysis in the era of pharmacogenomicsChristopher R Flowers, David Veenstra
Journal of Oncology Practice|August 15, 2013
Communicating safe outpatient management of fever and neutropeniaChristopher R Flowers, Clare Karten
Hematology. American Society of Hematology. Education Program|December 9, 2023
Barriers to accessing cellular therapy for patients receiving care in community practicesChijioke Nze, Christopher R Flowers
Journal of Oncology Practice|December 13, 2017
When to Choose Transplant in Follicular Lymphoma: Navigating a Complex LandscapeCarla Casulo, Christopher R Flowers
Current Oncology (Toronto, Ont.)|May 27, 2025
Patient-Reported Outcome Measures (PROMS) in LymphomaNeha Akkad, Christopher R Flowers
Pageof 43

Showing results (1-10 of 430) with videos related to

Sort By:
Pageof 43
Oncology (Williston Park, N.Y.)|April 6, 2010
Improving our use and understanding of antibodies in B-cell lymphomasChristopher R Flowers
Oncology (Williston Park, N.Y.)|September 17, 2014
Routine use of maintenance therapy in follicular lymphoma: examine the rationale for maintenance use before uniformly adopting a strategyChristopher R Flowers
Expert Review of Vaccines|June 5, 2007
BiovaxID idiotype vaccination: active immunotherapy for follicular lymphomaChristopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Reply to H.J.A. Adams et alQian Shi, Christopher R Flowers
Cancer|November 19, 2013
Racial differences in chronic lymphocytic leukemia. Digging deeperChristopher R Flowers, Barbara Pro
Pharmacoeconomics|June 26, 2004
The role of cost-effectiveness analysis in the era of pharmacogenomicsChristopher R Flowers, David Veenstra
Journal of Oncology Practice|August 15, 2013
Communicating safe outpatient management of fever and neutropeniaChristopher R Flowers, Clare Karten
Hematology. American Society of Hematology. Education Program|December 9, 2023
Barriers to accessing cellular therapy for patients receiving care in community practicesChijioke Nze, Christopher R Flowers
Journal of Oncology Practice|December 13, 2017
When to Choose Transplant in Follicular Lymphoma: Navigating a Complex LandscapeCarla Casulo, Christopher R Flowers
Current Oncology (Toronto, Ont.)|May 27, 2025
Patient-Reported Outcome Measures (PROMS) in LymphomaNeha Akkad, Christopher R Flowers
Pageof 43